RNA-sequencing analysis of HepG2 cells treated with atorvastatin.
The cholesterol-lowering drug atorvastatin is among the most prescribed drug in the world. Alternative splicing in a number of genes has been reported to be associated with variable statin response. RNA-seq has proven to be a powerful technique for genome-wide splice variant analysis. In the present...
Main Authors: | Camilla Stormo, Marianne K Kringen, Robert Lyle, Ole Kristoffer Olstad, Daniel Sachse, Jens P Berg, Armin P Piehler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4143339?pdf=render |
Similar Items
-
Copy number variations of the ATP-binding cassette transporter <it>ABCC6</it> gene and its pseudogenes
by: Kringen Marianne K, et al.
Published: (2012-08-01) -
Transformation of HepG2 nascent lipoproteins by LCAT: modulation by HepG2 d > 1.235 g/ml fraction.
by: MR McCall, et al.
Published: (1993-01-01) -
Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin
by: Lisa J. Wilcox, et al.
Published: (1999-06-01) -
Regulation of squalene epoxidase in HepG2 cells.
by: Y Hidaka, et al.
Published: (1990-11-01) -
Effects of nucleosides on the induction of apoptosis in HepG2 and Hep3B cells.
by: Che-Lin Chiu, et al.
Published: (2003)